Anti-LGI1 antibody (STJA0008992)

SKU:
STJA0008992

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Leucine-rich glioma-inactivated protein 1 is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: LGI1
Gene ID: 9211
Uniprot ID: LGI1_HUMAN
Specificity: This antibody detects endogenous levels of LGI1 at Human, Mouse, Rat
Immunogen: Synthesized peptide derived from human LGI1
Post Translational Modifications Glycosylated.
Function Regulates voltage-gated potassium channels assembled from KCNA1, KCNA4 and KCNAB1. It slows down channel inactivation by precluding channel closure mediated by the KCNAB1 subunit. Ligand for ADAM22 that positively regulates synaptic transmission mediated by AMPA-type glutamate receptors. Plays a role in suppressing the production of MMP1/3 through the phosphatidylinositol 3-kinase/ERK pathway. May play a role in the control of neuroblastoma cell survival.
Protein Name Leucine-Rich Glioma-Inactivated Protein 1
Epitempin-1
Database Links Reactome: R-HSA-5682910
Cellular Localisation Secreted
Synapse
Cytoplasm
Isoform 1: Golgi Apparatus
Isoform 2: Endoplasmic Reticulum
Alternative Antibody Names Anti-Leucine-Rich Glioma-Inactivated Protein 1 antibody
Anti-Epitempin-1 antibody
Anti-LGI1 antibody
Anti-EPT antibody
Anti-UNQ775 antibody
Anti-PRO1569 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance